Back to Search
Start Over
Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
- Source :
-
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Mar; Vol. 50 (5), pp. 987-96. Date of Electronic Publication: 2014 Jan 15. - Publication Year :
- 2014
-
Abstract
- Background: Constitutional mismatch repair deficiency (CMMRD) is a devastating cancer predisposition syndrome for which data regarding clinical manifestations, molecular screening tools and management are limited.<br />Methods: We established an international CMMRD consortium and collected comprehensive clinical and genetic data. Molecular diagnosis of tumour and germline biospecimens was performed. A surveillance protocol was developed and implemented.<br />Results: Overall, 22/23 (96%) of children with CMMRD developed 40 different tumours. While childhood CMMRD related tumours were observed in all families, Lynch related tumours in adults were observed in only 2/14 families (p=0.0007). All children with CMMRD had café-au-lait spots and 11/14 came from consanguineous families. Brain tumours were the most common cancers reported (48%) followed by gastrointestinal (32%) and haematological malignancies (15%). Importantly, 12 (30%) of these were low grade and resectable cancers. Tumour immunohistochemistry was 100% sensitive and specific in diagnosing mismatch repair (MMR) deficiency of the corresponding gene while microsatellite instability was neither sensitive nor specific as a diagnostic tool (p<0.0001). Furthermore, screening of normal tissue by immunohistochemistry correlated with genetic confirmation of CMMRD. The surveillance protocol detected 39 lesions which included asymptomatic malignant gliomas and gastrointestinal carcinomas. All tumours were amenable to complete resection and all patients undergoing surveillance are alive.<br />Discussion: CMMRD is a highly penetrant syndrome where family history of cancer may not be contributory. Screening tumours and normal tissues using immunohistochemistry for abnormal expression of MMR gene products may help in diagnosis and early implementation of surveillance for these children.<br /> (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Subjects :
- Adaptor Proteins, Signal Transducing genetics
Adaptor Proteins, Signal Transducing metabolism
Adenosine Triphosphatases genetics
Adenosine Triphosphatases metabolism
Adolescent
Cafe-au-Lait Spots diagnosis
Cafe-au-Lait Spots genetics
Cafe-au-Lait Spots metabolism
Child
Child, Preschool
DNA Repair Enzymes genetics
DNA Repair Enzymes metabolism
DNA-Binding Proteins genetics
DNA-Binding Proteins metabolism
Family Health
Female
Humans
Immunohistochemistry
Infant
Male
Mismatch Repair Endonuclease PMS2
MutL Protein Homolog 1
MutS Homolog 2 Protein genetics
MutS Homolog 2 Protein metabolism
Neoplasms diagnosis
Neoplasms genetics
Neoplasms metabolism
Nuclear Proteins genetics
Nuclear Proteins metabolism
Pedigree
Syndrome
DNA Mismatch Repair genetics
Microsatellite Instability
Mutation
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0852
- Volume :
- 50
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- European journal of cancer (Oxford, England : 1990)
- Publication Type :
- Academic Journal
- Accession number :
- 24440087
- Full Text :
- https://doi.org/10.1016/j.ejca.2013.12.005